|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/768 | (2015.01) |
| A61K 9/0019 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 35/765 | (2015.01) | ||
| A61K 35/761 | (2013.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 35/763 | (2013.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 35/765 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 35/766 | (2013.01) | ||
| A61K 35/768 | (2013.01) | ||
| A61K 35/761 | (2015.01) | ||
| A61K 35/763 | (2015.01) | ||
| A61K 47/02 | (2013.01) | ||
| A61K 35/766 | (2015.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 14/535 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| C12N 9/10 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| C12N 9/80 | (2006.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07K 14/535 | (2013.01) | ||
| C07K 16/2818 | (2013.01) | ||
| C07K2317/55 | (2013.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C12N 9/1077 | (2013.01) | ||
| C12N 9/80 | (2013.01) | ||
| C12N2710/24121 | (2013.01) | ||
| C12N2710/24132 | (2013.01) | ||
| C12Y 204/02009 | (2013.01) | ||
| C12Y 305/01023 | (2013.01) |
| (11) | Patento numeris | 3552615 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19174121.4 |
| Europos patento paraiškos padavimo data | 2015-07-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-01-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 14306153 | 2014-07-16 | EP |
| (72) |
SILVESTRE, Nathalie , FR
GEIST, Michel , FR
RITTNER, Karola , FR
MARCHAND, Jean-Baptiste , FR
THIOUDELLET, Christine , FR
|
| (73) |
TRANSGENE ,
Parc d'Innovation
Boulevard Gonthier d'Andernach, 67400 Illkirch Graffenstaden,
FR
|
| (54) | ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |
| ONCOLYTIC VIRUS FOR EXPRESSION OF IMMUNE CHECKPOINT MODULATORS |